Recruiting Heart Attack Studies in Stamford
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
The purpose of this trial is to determine which doses of Lu AG09222 are recommended to help prevent migraines. People who join this trial have already tried 1 to 4 other available medications to preve...
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine....
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)
The trial will evaluate efficacy, safety and tolerability of two regimens of ianalumab compared to placebo, given as monthly or quarterly subcutaneous (s.c.) injection on top of standard-of-care (SoC)...
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants....
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine....
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age....
About Heart Attack Clinical Trials in Stamford
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 6 heart attack clinical trials recruiting participants in Stamford, CT. These studies are seeking a combined 2,583 participants. Research is being sponsored by H. Lundbeck A/S, Novartis Pharmaceuticals, Upsher-Smith Laboratories. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Stamford — FAQ
Are there heart attack clinical trials in Stamford?
Yes, there are 6 heart attack clinical trials currently recruiting in Stamford, CT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stamford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stamford research site will contact you about next steps.
Are clinical trials in Stamford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stamford studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 6 active trials in Stamford are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov